Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TS03 Inc Trust Units TSTIF

Healthcare Medical Instruments & Supplies


GREY:TSTIF - Post by User

TS03 Inc Trust Units > TSO3 's Chief Science Officer to Moderate IAHCSMM Panel
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(15)
•••
Comment by Dr.Cashon Apr 27, 2018 10:42am
177 Views
Post# 27949873

RE:TSO3 's Chief Science Officer to Moderate IAHCSMM Panel

RE:TSO3 's Chief Science Officer to Moderate IAHCSMM Panel Echo, This share price is so far out of line with what is going on with TSO3 that there has to be someone in the back ground waiting for the Duo approval to take a shot at buying the company, and they are the ones keeping the price down.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities